​

Ernexa Therapeutics Ownership | Who Owns Ernexa Therapeutics?

OverviewRevenueFinancialsChart

Ernexa Therapeutics Ownership Summary

Ernexa Therapeutics is owned by 2.79% institutional investors, 73.98% insiders, and 23.23% retail investors. Activest wealth management is the largest institutional shareholder, holding 0% of ERNA shares. Fidelity Extended Market Index is the top mutual fund, with 0.17% of its assets in Ernexa Therapeutics shares.

ERNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockErnexa Therapeutics2.79%73.98%23.23%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Activest wealth management---
Geode capital management---
Vanguard personalized indexing management---
Cypress point wealth management---
Two sigma securities---
Eversource wealth advisors---
Montag a & associates---
Assetmark---
Ci private wealth---
Jpmorgan chase---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Activest wealth management---
Geode capital management---
Vanguard personalized indexing management---
Cypress point wealth management---
Two sigma securities---
Eversource wealth advisors---
Montag a & associates---
Assetmark---
Ci private wealth---
Jpmorgan chase---

Top Buyers

HolderShares% AssetsChange
Group one trading---19.00
Activest wealth management---50.00
Jpmorgan chase---53.00
Montag a & associates---141.00
Eversource wealth advisors---1.75K

Top Sellers

HolderShares% AssetsChange
Geode capital management---293.15K
Ci private wealth---262.86K
Two sigma securities---229.34K
Citigroup---153.16K
Cypress point wealth management---94.38K

Sold Out

HolderChange
Group one trading-19.00
Activest wealth management-50.00
Jpmorgan chase-53.00
Montag a & associates-141.00
Eversource wealth advisors-1.75K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025268.33%1,488,38549.68%25.25%129.09%525.00%
Dec 31, 20242420.00%994,39339.80%74.22%11120.00%433.33%
Sep 30, 2024205.26%711,29982.35%1325.29%5-3200.00%
Jun 30, 202419-13.64%390,079-4.67%712.60%5-28.57%1-
Mar 31, 20242215.79%409,206-53.29%72.78%775.00%1-80.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index13.01K0.17%-92.00
Vanguard Institutional Extnd Mkt Idx Tr10.47K0.14%8.33K
BlackRock Extended Equity Market K2.28K0.04%-1.00
Fidelity Series Total Market Index3.19K0.04%-
Spartan Extended Market Index Pool F3.13K0.04%92.00
Fidelity Nasdaq Composite Index1.17K0.02%-
Vanguard Total Stock Mkt Idx Inv12.09K0.02%-
SSgA U.S. Extended Market Index Class I766.000.01%-
Spartan Total Market Index Pool G608.000.01%-
Extended Equity Market Fund M290.000.01%-1.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 09, 2025Cherington Charles-Buy$2.22M
Sep 24, 2024Cherington Charles-Buy-
Sep 24, 2024Cherington Charles-Buy$1.77M
Sep 24, 2024Cherington Charles-Buy$2.24M
Sep 24, 2024Cherington Charles-Buy-

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q473
2024 Q34-
2024 Q2--

ERNA Ownership FAQ

Who Owns Ernexa Therapeutics?

Ernexa Therapeutics shareholders are primarily institutional investors at 2.79%, followed by 73.98% insiders and 23.23% retail investors. The average institutional ownership in Ernexa Therapeutics's industry, Biotech Stocks , is 306.59%, which Ernexa Therapeutics falls below.

Who owns the most shares of Ernexa Therapeutics?

Ernexa Therapeutics’s largest shareholders are Activest wealth management (0 shares, 0%), Geode capital management (0 shares, 0%), and Vanguard personalized indexing management (0 shares, 0%). Together, they hold 0% of Ernexa Therapeutics’s total shares outstanding.

Does Blackrock own Ernexa Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Ernexa Therapeutics.

Who is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested?

Activest wealth management is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Ernexa Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Ernexa Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Ernexa Therapeutics shares, with 0.17% of its total shares outstanding invested in 13K Ernexa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools